Akt inhibitor A-443654 interferes with mitotic progression by regulating Aurora A kinase expression

Neoplasia

Volumn 10, Issue 8, 2008, Pages 828-837

  Liu, Xuesong ^a   Shi, Yan ^a   Woods, Keith W ^a   Hessler, Paul ^a   Kroeger, Paul ^a   Wilsbacher, Julie ^a   Wang, Jieyi ^a   Wang, Jean Y ^b   Li, Chunying ^c   Li, Qun ^a   Rosenberg, Saul H ^a   Giranda, Vincent L ^a   Luo, Yan ^a  

^a ABBOTT LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; A 443654; AURORA A KINASE; DNA; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR;

ARTICLE; CELL CYCLE G2 PHASE; CELL LEVEL; CENTROSOME; CONTROLLED STUDY; DNA SEQUENCE; DRUG INHIBITION; DRUG STRUCTURE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MITOSIS SPINDLE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 48249138744     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.08408     Document Type: Article

References (48)

1. Datta SR, Brunet A, and Greenberg ME (1999). Cellular survival: a play in three Akts. Genes Dev 13, 2905-2927.
2. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, and Cohen P (1997). Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bá. Curr Biol 7, 261-269.
3. Balendran A, Casamayor A, Deak M, Paterson A, Gaffney P, Currie R, Downes CP, and Alessi DR (1999). PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol 9, 393-404.
4. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, and Dedhar S (2001). Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 276, 27462-27469.
5. Toker A and Newton AC (2000). Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem 275, 8271-8274.
6. Feng J, Park J, Cron P, Hess D, and Hemmings BA (2004). Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem 279, 41189-41196.
7. Sarbassov DD, Guertin DA, Ali SM, and Sabatini DM (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
8. Blume-Jensen P and Hunter T (2001). Oncogenic kinase signalling. Nature 411, 355-365.
9. kip1. Nature 404, 782-787.
10. 1 arrest. Nat Med 8, 1153-1160.
11. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, and Arteaga CL (2002). PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8, 1145-1152.
12. Kandel ES, Skeen J, Majewski N, Di CA, Pandolfi PP, Feliciano CS, Gartel A, and Hay N (2002). Activation of Akt/protein kinase B overcomes a G(2)/M cell cycle checkpoint induced by DNA damage. Mol Cell Biol 22, 7831-7841.
13. Dangi S, Cha H, and Shapiro P (2003). Requirement for phosphatidylinositol-3 kinase activity during progression through S-phase and entry into mitosis. Cell Signal 15, 667-675.
14. 2/M phase of the cell cycle. Curr Biol 12, 919-924.
15. Lee S-R, Park J-H, Park EK, Chung CH, Kang S-S, and Bang O-S (2005). Akt-induced promotion of cell cycle progression at G(2)/M phase involves upregulation of NF-Y binding activity in PC12 cells. J Cell Physiol 205, 270-277.
16. Roberts EC, Shapiro PS, Nahreini TS, Pages G, Pouyssegur J, and Ahn NG (2002). Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis. Mol Cell Biol 22, 7226-7241.
17. 2/M-phase transition. Nat Cell Biol 4, 111-116.
18. 2/M transition. Mol Cell Biol 25, 5725-5737.
19. Shtivelman E (2003). Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR. Mol Cancer Res 1, 959-969.
20. Andrews PD (2005). Aurora kinases: shining lights on the therapeutic horizon? Oncogene 24, 5005-5015.
21. Carmena M and Earnshaw WC (2003). The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 4, 842-854.
22. Meraldi P, Honda R, and Nigg EA (2004). Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr Opin Genet Dev 14, 29-36.
23. Liu Q and Ruderman JV (2006). Aurora A, mitotic entry, and spindle bipolarity. Proc Natl Acad Sci USA 103, 5811-5816.
24. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, et al. (1998). A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 17, 3052-3065.
25. Meraldi P, Honda R, and Nigg EA (2002). Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 21, 483-492.
26. Anand S, Penrhyn LS, and Venkitaraman AR (2003). AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3, 51-62.
27. Yang H, Burke T, Dempsey J, Diaz B, Collins E, Toth J, Beckmann R, and Ye X (2005). Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase. FEBS Lett 579, 3385-3391.
28. Hirota T, Kunitoku N, Sasayama T, Marumoto T, Zhang D, Nitta M, Hatakeyama K, and Saya H (2003). Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 114, 585-598.
29. Murata HM, Tatsuka M, and Wang YL (2002). Probing the dynamics and functions of aurora B kinase in living cells during mitosis and cytokinesis. Mol Biol Cell 13, 1099-1108.
30. Luo Y, Shoemaker AR, Liu X, Woods KW, Thomas SA, de Jong R, Han EK, Li T, Stoll VS, Powlas JA, et al. (2005). Potent and selective inhibitors of Akt kinases slow the progression of tumors in vivo. Mol Cancer Ther 4, 977-986.
31. Shi Y, Liu X, Han E-K, Guan R, Shoemaker AR, Oleksijew A, Woods KW, Fisher JP, Klinghofer V, Lasko L, et al. (2005). Optimal classes of chemotherapeutics sensitized by specific small molecule inhibitors of Akt in vitro and in vivo. Neoplasia 7, 922-1000.
32. Tanaka M, Ueda A, Kanamori H, Ideguchi H, Yang J, Kitajima S, and Ishigatsubo Y (2002). Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J Biol Chem 277, 10719-10726.
33. Marumoto T, Honda S, Hara T, Nitta M, Hirota T, Kohmura E, and Saya H (2003). Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. J Biol Chem 278, 51786-51795.
34. Giet R and Prigent C (1999). Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. J Cell Sci 112, 3591-3601.
35. Giet R and Prigent C (2000). The Xenopus laevis aurora/Ip11p-related kinase pEg2 participates in the stability of the bipolar mitotic spindle. Exp Cell Res 258, 145-151.
36. Marumoto T, Zhang D, and Saya H (2005). Aurora-A - a guardian of poles. Nat Rev Cancer 5, 42-50.
37. Giet R, McLean D, Descamps S, Lee Michael J, Raff-Jordan W, Prigent C, and Glover DM (2002). Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules. J Cell Biol 156, 437-451.
38. Hannak E, Kirkham M, Hyman AA, and Oegema K (2001). Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans. J Cell Biol 155, 1109-1116.
39. Giet R, Uzbekov R, Cubizolles F, Le Guellec K, and Prigent C (1999). The Xenopus laevis aurora-related protein kinase pEg2 associates with and phosphorylates the kinesin-related protein XlEg5. J Biol Chem 274, 15005-15013.
40. Gadea BB and Ruderman JV (2005). Aurora kinase inhibitor ZM447439 blocks chromosome-induced spindle assembly, the completion of chromosome condensation, and the establishment of the spindle integrity checkpoint in Xenopus egg extracts. Mol Biol Cell 16, 1305-1318.
41. Liu X, Shi Y, Birnbaum MJ, Ye K, De Jong R, Oltersdorf T, Giranda VL, and Luo Y (2006). Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions. J Biol Chem 281, 31380-31388.
42. Smith JL, Schaffner AE, Hofmeister JK, Hartman M, Wei G, Forsthoefel D, Hume DA, and Ostrowski MC (2000). ets-2 is a target for an Akt (protein kinase B)/Jun N-terminal kinase signaling pathway in macrophages of motheatenviable mutant mice. Mol Cell Biol 20, 8026-8034.
43. Galetic I, Maira SM, Andjelkovic M, and Hemmings BA (2003). Negative regulation of ERK and Elk by protein kinase B modulates c-fos transcription. J Biol Chem 278, 4416-4423.
44. Figueroa C and Vojtek AB (2003). Akt negatively regulates translation of the ternary complex factor Elk-1. Oncogene 22, 5554-5561.
45. Yu X, Minter DK, Malureanu L, Zhao-Wei M, Zhang D, Merkle CJ, Ward IM, Saya H, Fang G, van Deursen J, et al. (2005). Chfr is required for tumor suppression and Aurora A regulation. Nat Genet 37, 401-406.
46. Yang H, He L, Kruk P, Nicosia SV, and Cheng JQ (2006). Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int J Cancer 119, 2304-2312.
47. Wang X, Zhou YX, Qiao W, Tominaga Y, Ouchi M, Ouchi T, and Deng CX (2006). Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 25, 7148-7158.
48. Keen N and Taylor S (2004). Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 4, 927-936.